Showing posts from tagged with: Mark Robson MD

Pathway Genomics Announces Partnership with PROMPT Patient Registry to Advance Hereditary Cancer Research

Posted on 11/17/2014 in News, Press Releases

SAN DIEGO, CANovember 17, 2014Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced today that it has partnered with the Prospective Registry of Multiplex Testing (PROMPT), an online registry for patients who have undergone testing for cancer-causing genetic mutations. PROMPT is a recently formed consortium of physicians and scientists at academic centers across the nation, including Memorial Sloan Kettering Cancer Center, Mayo Clinic, Abramson Cancer Center of the University of Pennsylvania, and the Dana-Farber Cancer Institute. "We are honored to collaborate with the country’s leading cancer experts to help advance the understanding of cancer risk, the genes associated with it, and take steps to end preventable hereditary cancers,” said David Becker, Ph.D., Pathway Genomics’ chief scientific officer. The goal of the registry is to provide vital data needed to better understand the level of risk associated with and outcomes following testing for “panels” of cancer-associated genes. Key milestones were reached this summer, with the completion of the patient online portal in July and ethical approval in August to begin to patient enrollment on the first phase of the study.